Načítá se...
Immunomodulatory Drugs in the Management of SARS-CoV-2
With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain disease-modifying drugs that are used for the management of inflammatory disorders such as rheumatoid arthritis, spondyloarthrosis...
Uloženo v:
Hlavní autoři: | , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Frontiers Media S.A.
2020-08-01
|
Edice: | Frontiers in Immunology |
Témata: | |
On-line přístup: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01844/full |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|